Latest Updates

The Inflation Reduction Act (IRA) is triggering increases in Medicare beneficiaries’ spending on their Part B drugs.

Results from a survey released by the American Society for Radiation Oncology (ASTRO) indicate that further cuts to Medicare for radiation treatment would have a damaging impact on cancer care, increasing patient wait times and forcing clinics to cut staff or even close.

Indiana is trying a new strategy for controlling health benefits costs: limiting what the biggest nonprofit hospital systems in the state can charge employers for care.

As artificial intelligence (AI) works its way into everyday practice in community oncology, various challenges have emerged.

HARRISBURG — Democratic lawmakers have narrowed the scope of a proposed crackdown on hospital mergers and acquisitions, focusing it on private equity and excluding nonprofit operators from additional oversight after pushback from the industry’s powerful lobby.

Health care costs are out of control, hitting Californians in the form of higher premiums, higher deductibles and higher costs at the pharmacy counter. Millions of patients risk foregoing critical treatments because they cannot afford the co-payments and out-of-pocket costs.

Beyond providing quality health care, tax-exempt hospitals have substantial responsibilities to the public. These hospitals not only avoid nearly all taxes — they also reap billions of dollars in financial benefits from a federal prescription drug program known as 340B.

Are artificial intelligence and other technology advances “the road to nirvana” in community oncology? “I'm so excited about digital healthcare implementation,” says Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology and president of the Community Oncology Alliance (COA).

On May 13th, the Centers for Medicare & Medicaid Services (CMS) Administrator, Dr. Mehmet Oz, and CMS Deputy Administrator and Innovation Center Director, Abe Sutton, hosted a webinar to discuss a new strategic direction for the Center for Medicare and Medicaid Innovation (CMMI).

From the rising costs of cancer care to rolling back diversity, equity, and inclusion initiatives and reductions in cancer research funding, community oncology is facing big changes, says Susan Sabo-Wagner, MSN, RN, the vice president of clinical innovation at the American Oncology Network.